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It was recently suggested that intravenously administered plasma as determined by an in vitro transfection assay. In lipoplexes serve as a depot for the extracellular release of spite of this high level of transcriptionally active DNA, there naked DNA and it is the naked DNA that mediates gene was no significant gene expression in the lung or any other delivery in the lung. If this is the mechanism responsible organ tested. In addition, when lipoplex containing a for gene expression, we reasoned that continuous infusion reporter gene was injected, followed by an infusion of nonof plasmid DNA should also result in significant lung coding plasmid DNA as a potential competing molecule for expression in the absence of lipoplexes. Moreover, the DNA released from the lipoplex there was no effect on infusion of non-coding plasmid DNA should inhibit gene gene expression. These experiments indicate that the catdelivery by lipoplexes. Infusion of plasmid DNA at a rate ionic lipid component of the lipoplex functions in an active of 80 g/min into the tail vein of a mouse resulted in a DNA capacity beyond that of a simple passive release matrix for serum concentration of 800 g/ml. This was equivalent to plasmid DNA. a transcriptionally active DNA concentration of 120 g/ml Keywords: DNA; infusion; mechanism; nonviral Lipoplex-mediated gene delivery 1, 2 in vivo was demonstrated by the pioneering work of Brigham and colleagues. 3 Since then, many cationic lipid-based gene delivery protocols have entered clinical trials. [4] [5] [6] [7] [8] [9] Despite this progress, the mechanism(s) by which lipoplexes deliver genes in vivo has not been elucidated.
Recently, Song et al 10 injected cationic liposomes intravenously (i.v.) 5 min before an i.v. injection of a reporter gene. Surprisingly, the level of transgene expression in the lung was the same as that obtained following injection of the preformed lipoplex. Based on these data, Song et al suggested that extracellular DNA released from the lipoplex is the transfectionally active agent, and that the cationic lipid component serves only to increase pulmonary retention of DNA following systemic administration. 10 Given that naked plasmid DNA is capable of transfecting striated muscle 11, 12 , the thyroid gland 13 , the liver 14 , the lung 15 , solid tumors 16 and synovial tissue 17 , we found Song's observations intriguing and believed the hypothesis to be an important conjecture. If the proposal is correct, then any sustained release system for DNA should mediate transfection in the lung. Potentially, one could obtain gene expression without the adverse effects associated with the cationic lipid.
We repeated Liu's experiments and confirmed the observations. The pre-injection of cationic liposomes, followed 5 min later by a luciferase reporter gene, yielded To test our hypothesis, we defined the time-period within which lung transfection occurs upon systemic injection of cationic lipoplex by the subsequent i.v. injection of anionic liposomes. This strategy causes lipoplex dissociation in vitro. 18 We determined that lipoplex integrity is critical for lung transfection only in the first 60 min after its injection (Barron, Gagné and Szoka, Hum Gene Ther, in press). Following this time-period, clearance of lipoplex from the lung and other tissues by anionic liposome injection did not significantly influence transfection. This suggests that pulmonary uptake of the transcriptionally active species occurs substantially within the first 60 min after lipoplex injection.
We have previously shown that a 30 g dose of DNA complexed with cationic lipids yielded significant transfection activity in the lung upon i.v. injection into the mouse. 19 Our first objective was to infuse DNA to a steady-state plasma DNA concentration (C ss ) that was similar to the 30 g DNA dose administered through our standard lipoplex-based transfection protocol. Employing the published elimination rate for plasmid DNA of 1.4 ml/min, 20 the necessary infusion rate to achieve a C ss of 60 g DNA per ml plasma is 84 g/min.
Where R 0 is the infusion rate in g/min, C ss is the steadystate plasma concentration in g/l and Cl is the clearance rate in l/min.
We infused four mice with plasmid DNA via the tail vein as outlined in Table 1 and determined the plasma concentration and integrity of the infused plasmid DNA at its C ss . The 10 min infusion caused no apparent toxicity in the animals. The DNA was extracted from plasma and quantified via UV spectroscopy ( Table 1 ). The mean concentration of plasmid DNA in plasma was determined by optical density to be 496 g/ml or eight-fold greater than that of the value calculated through the equation and had a high A 260 /A 280 ratio, indicating that the extracted DNA was free of significant protein contamination. As a control, the extraction protocol was applied to plasma from animals into which we had not infused plasmid DNA. As expected, virtually no DNA was detected by absorbance (260 nm) ( Table 1) . Thus, high plasma DNA concentrations can be achieved using this infusion protocol.
To determine the size and integrity of the circulating plasmid DNA at C ss , the extracted DNA was subjected to agarose gel electrophoresis ( Figure 1 ). Figure 1 is a reproduction of an agarose gel through which a typical DNA sample obtained from the infused mice was electrophoresed. To confirm the identity of the DNA observed on the gel, we included native and restricted plasmid controls (lanes 1 and 2). Lane 3 contains DNA Although plasmid DNA degradation occurred, there was a significant proportion of high molecular weight DNA present in the extracted sample. The amount of ethanol precipitable DNA that remained in plasma as quantified by absorption was 496 g or 62% of the 800 g originally infused. Upon extraction of DNA from an animal infused for 60 min, we found a similar gel electrophoresis profile with even higher plasma DNA concentration (810 g/ml). The fact that the measured plasma DNA concentration was much higher than that of the calculated value is presumably a reflection of the saturation of DNA clearance mechanisms. A similar phenomenon was observed by Emlen and Mannik 21 upon bolus injections of single-stranded DNA. These investigators observed that single-stranded DNA was removed by the liver in a manner that could be described by MichaelisMenten kinetics.
After determining that the infusion protocol established a high plasma DNA concentration, we measured the fraction of the extracted high molecular weight DNA that was transcriptionally active. To accomplish this, a standard curve was established in an in vitro transfection assay that facilitated the measurement of luciferase activity in the extracted DNA. Non-coding DNA that had been previously infused into mice was extracted from plasma and combined with varying amounts of intact luciferase plasmid to yield 3 g of total DNA. The DNA was then complexed with fractured polyamidoamine dendrimer. 22 The resulting polyplex was used to transfect CV-1 fibroblasts in a 96-well culture plate. A 3 g aliquot of luciferase plasmid harvested from the plasma of infused animals was then used to transfect CV-1 cells in a similar fashion. Luciferase activity was assayed 48 h following transfection (Figure 2) . Extrapolation of the reporter gene activity to the standard curve indicated that between 5 and 15% of the extracted DNA is transcriptionally active. Given that about 800 g/ml concentration of high molecular weight DNA is in plasma after the 60 min infusion, this corresponds to 40-120 g of transcriptionally active DNA present in the blood at steady-state during the infusion procedure.
Based on the data presented in Table 1 and Figures 1  and 2 , it is clear that the infusion procedure outlined in Figure 3 establishes a significant plasma concentration of high molecular weight, transcriptionally active DNA. The transfection activity mediated by this i.v. infusion protocol was then compared with that of lipoplex-mediated systemic transfection. Mice were either infused via the tail vein with luciferase plasmid DNA for 60 min, corresponding to the established critical time-window of lipoplex transfection, or received a bolus injection of lipoplex containing the luciferase plasmid. Luciferase gene expression in the heart, lung, liver and spleen was measured 24 h after administration (Figure 3 ). Pulmonary reporter gene activity in the plasmid DNA-infused animals was greater than three orders-of-magnitude lower than in animals receiving a lipoplex bolus and not significantly higher than animals treated with saline alone (Figure 3) . A similar pattern was shown in the heart, liver and spleen.
Since the infusion procedure involved the introduction of 1.2 ml of buffer into the circulation of the mouse, there was potential for the buffer itself to have significant effects in the blood. To ensure that artifacts due to electrolyte dilution or excessive glucose load were not observed, we repeated the infusion procedure with DNA dissolved in phosphate-buffered saline (PBS). DNA dissolved in PBS yielded similar results to that of the glucose-based buffer when infused i.v., therefore, we conclude that the buffer in which the DNA is dissolved had no significant effect on subsequent gene expression. These data demonstrate that free DNA is not capable of transfection in the tissues assayed, even when it is present in the blood in significant transcriptionally active quantities.
We further reasoned that if the release of free plasmid DNA from the lipoplex mediates transfection, then a high plasma concentration of non-coding plasmid DNA should compete with the coding plasmid for cell uptake and transfection should decrease.
Lipoplex was administered as outlined in Figure 3 . We have previously observed that greater than 95% of the lipoplex is cleared from circulation 5 min after injection. 19 In order to avoid influencing lipoplex distribution, the infusion of non-coding DNA was initiated 5 min after lipoplex injection and maintained for 55 min thereafter. Animals were killed 24 h later for analysis of transgene expression in the heart, lung, liver and spleen (Figure 4) . The infusion of the non-coding DNA molecule did not decrease transfection in any organ assayed. The inability of the non-coding DNA to reduce transfection implies that there is no opportunity for it to compete with the initially complexed DNA for uptake; therefore, we conclude that the complexed DNA has been compartmentalized following injection either as a component of the lipoplex or through cellular uptake.
We have shown that the maintenance of significant plasma levels of high molecular weight, transcriptionally active DNA does not yield measurable transgene delivery in the heart, lung, liver or spleen. In addition, the infusion of non-coding plasmid DNA, a potential competitor for reporter DNA uptake, did not cause a decrease in transfection. These data do not support the hypothesis that DNA released from the lipoplex in the extracellular compartment is the transfectionally active agent observed in murine tissues upon i.v. administration of cationic lipid-DNA complex.
These data imply that the cationic lipid component of the lipoplex is an active component in the delivery of the gene and the lipoplex constitutes more than just a sustained release mechanism for plasmid DNA. Cationic lipids may interact directly with the cell membrane either by binding to it and initiating the endocytosis of DNA. 23 It is also possible that the cationic lipids act to bind specific plasma proteins to the lipoplex. These adsorbed proteins may then indirectly target the lipoplex to the lung endothelium by binding their cognate receptors in the pulmonary microvasculature. All of the above possibilities require the active participation of the cationic lipid component. 19 n = 4.
